Novavax to supply Covax with 1.1B COVID-19 vaccine doses Novavax announced a memorandum of understanding with Gavi, the Vaccine Alliance, to provide 1.1 billion cumulative doses of its COVID-19 vaccine candidate, NVX-CoV2373, to the Covax facility. The company has also fully enrolled participants in its pivotal phase III clinical trial of NVX-CoV2373.Read More
Thermo Fisher launches new electron microscope Thermo Fisher Scientific has unveiled its new Helios 5 PXL Wafer DualBeam, a plasma-focused ion beam scanning electron microscope. The microscope can reduce time-to-data from days to hours for inline through-stack metrology and verify high-aspect ratio structures, the firm said.Read More
Janssen's COVID-19 vaccine submitted to EMA for emergency use Johnson & Johnson announced that Janssen has submitted a conditional marketing authorization application to the European Medicines Agency (EMA) for its investigational single-dose Janssen COVID-19 vaccine candidate.Read More
Proteomics helps researchers pick the best anti-SARS-CoV-2 nanobodies A new high-throughput proteomics-based strategy to identify tiny antibody fragments -- called nanobodies -- may provide an efficient and effective method for developing therapeutics against the deadly SARS-CoV-2 virus -- including variants. The findings were published in Cell Systems on February 15.Read More